Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCORDE: Non-operable esophageal carcinoma treated with FOLFOX-4 chemoradiotherapy and high-dose radiotherapy
2010-018572-25Phase 2Completed
- Sponsor
- Centre Georges-François Leclerc
- Start
- Apr 2010
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of oxaliplatin, levoleucovorin and fluorouracil in esophageal cancer, sponsored by Centre Georges-François Leclerc. Primary endpoint: Primary endpoint phase II. Started Apr 2010; status: completed.
02
Drugs
oxaliplatinlevoleucovorinfluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on 2010-018572-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018572-25.